| Oral and Maxillofacial Pathology | Lifetime | 118 | GB 15 | 99.14 |
| Salivary Gland Tumors Diagnosis and Treatment | Lifetime | 185 | GB 14 | 98.62 |
| Cancer Diagnosis and Treatment | Lifetime | 454 | GB 30 | 97.74 |
| Head and Neck Cancer Studies | Lifetime | 451 | GB 25 | 98.27 |
| Dental Education, Practice, Research | Lifetime | 90 | GB 28 | 97.53 |
| Facial Trauma and Fracture Management | Lifetime | 157 | GB 10 | 97.63 |
| Diversity and Career in Medicine | Lifetime | 242 | GB 14 | 96.22 |
| Patient Safety and Medication Errors | Lifetime | 204 | GB 25 | 97.11 |
| Facial Nerve Paralysis Treatment and Research | Lifetime | 209 | GB 13 | 96.81 |
| Oral Health Pathology and Treatment | Lifetime | 332 | GB 42 | 97.06 |
| COVID-19 and healthcare impacts | Lifetime | 695 | GB 122 | 93.41 |
| Medical Malpractice and Liability Issues | Lifetime | 294 | GB 33 | 95.65 |
| Head and Neck Surgical Oncology | Lifetime | 792 | GB 31 | 96.85 |
| Innovations in Medical Education | Lifetime | 919 | GB 91 | 95.87 |
| Tumors and Oncological Cases | Lifetime | 465 | GB 23 | 96.05 |
| Ear and Head Tumors | Lifetime | 393 | GB 20 | 96.21 |
| Bone Tumor Diagnosis and Treatments | Lifetime | 710 | GB 37 | 95.79 |
| Oral health in cancer treatment | Lifetime | 245 | GB 27 | 94.53 |
| Craniofacial Disorders and Treatments | Lifetime | 669 | GB 47 | 93.89 |
| Medical Education and Admissions | Lifetime | 323 | GB 41 | 92.98 |
| Dental Anxiety and Anesthesia Techniques | Lifetime | 809 | GB 98 | 91.11 |
| Traumatic Ocular and Foreign Body Injuries | Lifetime | 842 | GB 59 | 89.29 |
| Soft tissue tumors and treatment | Lifetime | 505 | GB 36 | 76.88 |
| Oropharyngeal Anatomy and Pathologies | Lifetime | 768 | GB 30 | 71.74 |
| Lymphadenopathy Diagnosis and Analysis | Lifetime | 206 | GB 9 | 65.02 |
| Nasolacrimal Duct Obstruction Treatments | Lifetime | 869 | GB 65 | 61.77 |
| Oral and Maxillofacial Pathology | 2021-2025 | 43 | GB 4 | 97.15 |
| Diversity and Career in Medicine | 2021-2025 | 104 | GB 6 | 95.68 |
| Medical Education and Admissions | 2021-2025 | 27 | GB 3 | 96.04 |
| Innovations in Medical Education | 2021-2025 | 214 | GB 12 | 95.78 |
| Dental Education, Practice, Research | 2021-2025 | 26 | GB 7 | 92.57 |
| Head and Neck Cancer Studies | 2021-2025 | 417 | GB 12 | 94.18 |
| Medical Malpractice and Liability Issues | 2021-2025 | 119 | GB 16 | 87.34 |
| Patient Safety and Medication Errors | 2021-2025 | 203 | GB 17 | 85.61 |
| Bone Tumor Diagnosis and Treatments | 2021-2025 | 358 | GB 17 | 85.26 |
| Oral Health Pathology and Treatment | 2021-2025 | 567 | GB 31 | 79.16 |
| Salivary Gland Tumors Diagnosis and Treatment | 2021-2025 | 788 | GB 26 | 76.71 |
| Lymphadenopathy Diagnosis and Analysis | 2021-2025 | 23 | GB 3 | 73.00 |
| Reconstructive Facial Surgery Techniques | 2021-2025 | 561 | GB 15 | 73.70 |
| Ear and Head Tumors | 2021-2025 | 805 | GB 19 | 65.52 |
| Hospital Admissions and Outcomes | 2021-2025 | 258 | GB 9 | 64.60 |
| Facial Trauma and Fracture Management | 2021-2025 | 951 | GB 27 | 60.99 |
| Healthcare Quality and Management | 2021-2025 | 515 | GB 60 | 35.92 |
